Shanghai Kehua Bio-engineering Co Ltd - Class A

SZSE:002022 (China)   Class A
Â¥ 6.90 (+0.15%) Nov 29
At Loss
P/B:
0.90
Market Cap:
Â¥ 3.55B ($ 490.05M)
Enterprise V:
Â¥ 2.96B ($ 408.44M)
Volume:
8.90M
Avg Vol (2M):
10.90M
Trade In:
Volume:
8.90M
At Loss
Avg Vol (2M):
10.90M

Business Description

Shanghai Kehua Bio-engineering Co Ltd
NAICS : 325414
ISIN : CNE000001KC9

Share Class Description:

SZSE:002022: Class A
Description
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
Name Current Vs Industry Vs History
Cash-To-Debt 2.36
Equity-to-Asset 0.66
Debt-to-Equity 0.11
Debt-to-EBITDA -1.34
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.05
Distress
Grey
Safe
Beneish M-Score -2.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 66.6
9-Day RSI 61.21
14-Day RSI 59.49
6-1 Month Momentum % -2.11
12-1 Month Momentum % -29.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.55
Quick Ratio 3.17
Cash Ratio 1.35
Days Inventory 328.48
Days Sales Outstanding 216.52
Days Payable 107.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate 109.8
Shareholder Yield % 3.18
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Shanghai Kehua Bio-engineering Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 1,874.077
EPS (TTM) (Â¥) -0.658
Beta 0.75
Volatility % 52.53
14-Day RSI 59.49
14-Day ATR (Â¥) 0.235039
20-Day SMA (Â¥) 6.713
12-1 Month Momentum % -29.53
52-Week Range (Â¥) 5.05 - 11.85
Shares Outstanding (Mil) 514.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Shanghai Kehua Bio-engineering Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Shanghai Kehua Bio-engineering Co Ltd Stock Events

Financials Calendars
Event Date Price(Â¥)
No Event Data

Shanghai Kehua Bio-engineering Co Ltd Frequently Asked Questions

What is Shanghai Kehua Bio-engineering Co Ltd(SZSE:002022)'s stock price today?
The current price of SZSE:002022 is ¥6.90. The 52 week high of SZSE:002022 is ¥11.85 and 52 week low is ¥5.05.
When is next earnings date of Shanghai Kehua Bio-engineering Co Ltd(SZSE:002022)?
The next earnings date of Shanghai Kehua Bio-engineering Co Ltd(SZSE:002022) is .
Does Shanghai Kehua Bio-engineering Co Ltd(SZSE:002022) pay dividends? If so, how much?
Shanghai Kehua Bio-engineering Co Ltd(SZSE:002022) does not pay dividend.

Press Release

Subject Date
No Press Release